fulvestrant has been researched along with Hyperplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, MN; Chambon, P; Hogg, ME; Jiang, Q; Keefer, LK; Kibbe, MR; Martinez, J; Vavra, AK | 1 |
Huhtaniemi, I; Mäkelä, S; Pakarainen, T; Poutanen, M; Savolainen, S | 1 |
2 other study(ies) available for fulvestrant and Hyperplasia
Article | Year |
---|---|
The role of estrogen receptor α and β in regulating vascular smooth muscle cell proliferation is based on sex.
Topics: Animals; Cell Proliferation; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fulvestrant; Hyperplasia; Male; Mice; Mice, Knockout; Models, Animal; Muscle, Smooth, Vascular; Neointima; Nitric Oxide; Rats; Rats, Sprague-Dawley; Sex Characteristics; Signal Transduction | 2012 |
Delay of postnatal maturation sensitizes the mouse prostate to testosterone-induced pronounced hyperplasia: protective role of estrogen receptor-beta.
Topics: Animals; Aromatase Inhibitors; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Fulvestrant; Humans; Hyperplasia; Inflammation; Ki-67 Antigen; Male; Mice; Mice, Knockout; Nitriles; Phosphoproteins; Prolactin; Prostate; Receptors, Androgen; Receptors, LH; Receptors, Progesterone; Testosterone; Trans-Activators; Triazoles | 2007 |